Get started
Author

Joan Mendívil

Development of EMPRO: A Tool for the Standardized Assessment of Patient-Reported Outcome Measures
2008 · Jose M. Valderas, Montse Ferrer, et al. · Value in Health · 236
Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey
2021 · Joan Mendivil, Ryan Murphy, et al. · Orphanet Journal of Rare Diseases · 111
Construcción de un filtro geográfico para la identificación en PubMed de estudios realizados en España
2006 · José M. Valderas, Joan Mendivil, et al. · Revista Española de Cardiología · 70
Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department
2017 · Apoorva Ambavane, Bertil Lindahl, et al. · PLoS ONE · 66
PDF
Development of a Geographic Filter for PubMed to Identify Studies Performed in Spain
2006 · José M. Valderas, Joan Mendivil, et al. · Revista Española de Cardiología (English Edition) · 48
Correction: Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency department
2018 · Apoorva Ambavane, Bertil Lindahl, et al. · PLoS ONE · 38
PDF
A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis
2023 · Joan Mendivil, Maral DerSarkissian, et al. · Allergy Asthma and Clinical Immunology · 35
PDF
Evaluación de la calidad de vida de los pacientes con cáncer de próstata localizado: validación de la versión española del cuestionario EPIC
2009 · Montse Ferrer, Olatz Garin, et al. · Medicina Clínica · 34
Economic evaluations of screening strategies for the early detection of colorectal cancer in the average-risk population: A systematic literature review
2019 · Joan Mendivil, Marilena Appierto, et al. · PLoS ONE · 29
PDF
Long-Term Prediction of the Demand of Colonoscopies Generated by a Population-Based Colorectal Cancer Screening Program
2016 · Mercè Comas, Joan Mendivil, et al. · PLoS ONE · 28
PDF
Direct costs of unintended pregnancy in Spain
2015 · Iñaki Lete, Fareen Hassan, et al. · The European Journal of Contraception & Reproductive Health Care · 28
Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema
2023 · Magdalena Vanya, Maureen Watt, et al. · Journal of Patient-Reported Outcomes · 19
PDF
Speed cameras in an urban setting: a cost–benefit analysis
2011 · Joan Mendivil, Anna García-Altés, et al. · Injury Prevention · 13
A Core Outcome Set for Efficacy of Acute Treatment of Hereditary Angioedema
2024 · Remy S. Petersen, Lauré M. Fijen, et al. · The Journal of Allergy and Clinical Immunology In Practice · 10
PDF
Indirect Comparison of Lanadelumab and Intravenous C1-INH Using Data from the HELP and CHANGE Studies: Bayesian and Frequentist Analyses
2021 · Joan Mendivil, Mia Malmenäs, et al. · Drugs in R&D · 9
PDF
Assessing Patient-Reported Outcomes in Acute Attacks of Hereditary Angioedema: Insights from a Mixed Methods Study of Participants Receiving Standard-of-Care Treatments in a Real-World Setting
2026 · Joan Mendivil, Li Zhu, et al. · Clinical Reviews in Allergy & Immunology · 2
PDF
Análisis del desempeño de los servicios sanitarios de Cataluña: evaluación de los primeros resultados del proyecto demostrativo
2009 · Anna García-Altés, Albert Dalmau-Bueno, et al. · Gaceta Sanitaria · 2
PDF
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks: a phase 3, multicentre, randomised, double-blind, placebo-controlled crossover trial
2026 · Marc A Riedl, Philip H Li, et al. · The Lancet · 1
Cn3 Systematic Review of Economic Evaluations of Colorectal Cancer Screening Strategies for the Early Detection of Colorectal Cancer in the General Population
2019 · J. Mendivil, M. Appierto, et al. · Value in Health Regional Issues · 1
Oral Deucrictibant Extended-release Tablet for Prophylaxis of Hereditary Angioedema Attacks: the Phase 3 Chapter-3 Trial
2026 · Marc A Riedl, Adil Adatia, et al. · Annals of Allergy Asthma & Immunology
Patient Experience with Treatment of HAE Attacks: Results from a Real-World Survey of Physicians and Their Patients
2026 · John Anderson, Laurence Bouillet, et al. · Advances in Therapy
PDF
Angioedema due to acquired C1 inhibitor deficiency: patient experience, conceptual disease model, and assessment of patient-reported outcome measures
2026 · Mats de Lange, Danny M. Cohn, et al. · Frontiers in Immunology
PDF
Content Validity of the Angioedema syMptom Rating scAle (AMRA) to Assess Symptoms of Hereditary Angioedema Attacks
2026 · Teresa Caballero, Danny Cohn, et al. · Journal of Allergy and Clinical Immunology
Deucrictibant Vs. Standard of Care in Hereditary Angioedema: a Propensity Score-matched Analysis
2025 · M. Scarupa, J. Anderson, et al. · Annals of Allergy Asthma & Immunology
PCR238 Development of a Conceptual Model Supporting a Clinical Outcome Assessment Strategy for Acquired Angioedema Due to C1 Inhibitor Deficiency
2025 · Marc A. Riedl, Danny M. Cohn, et al. · Value in Health
Works count: 38
Citation count: 780
H-index: 13
I10-index: 14
Year
Topic
Type